CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 1, 2021 · PDUFA decision

ABBV PDUFA decision: an FDA approval, +1.1%

On February 1, 2021, AbbVie Inc. reached its PDUFA decision. The result was an FDA approval, and the stock moved +1.1% in the window around the event.

The move

$102.30
1d before
$102.30
Event day
$103.47
1d after
$108.73
5d after

Pre-catalyst setup

-1.2%
30-day run-up
2332%
30-day volatility
1.3×
volume spike